Nexstim Oyj: Arvopaperimarkkinalain 9 luvun 10 §:n mukainen ilmoitus huomattavasta omistusosuudesta
11 juin 2024 07h00 HE
|
Nexstim Oyj
Yhtiötiedote, Helsinki, 11.6.2024 klo. 14.00 (EEST) Nexstim Oyj: Arvopaperimarkkinalain 9 luvun 10 §:n mukainen ilmoitus huomattavasta omistusosuudesta Nexstim Oyj (NXTMH:HEX) (”Nexstim” tai...
Nexstim Plc: Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act
11 juin 2024 07h00 HE
|
Nexstim Oyj
Company announcement, Helsinki, 11 June 2024 at 2 PM (EEST) Nexstim Plc: Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act Nexstim Plc...
Distributor Orders Nexstim NBS System 5 for European Hospital
10 juin 2024 02h00 HE
|
Nexstim Oyj
Press release, Helsinki, 10 June 2024 at 9 AM (EEST) Distributor Orders Nexstim NBS System 5 for European Hospital Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS...
Sisäpiiritieto: Nexstim Oyj tiedottaa suunnitellusta yhteistyöstä Sinaptica Therapeutics, Inc:n kanssa Alzheimerin taudin hoidon alalla
07 juin 2024 02h00 HE
|
Nexstim Oyj
Yhtiötiedote, Helsinki, 07.06.2024 klo. 9.00 (EEST) Sisäpiiritieto: Nexstim Oyj tiedottaa suunnitellusta yhteistyöstä Sinaptica Therapeutics, Inc:n kanssa Alzheimerin taudin hoidon alalla Nexstim...
Insider Information: Nexstim Plc Announces Planned Alzheimer’s Collaboration with Sinaptica Therapeutics, Inc.
07 juin 2024 02h00 HE
|
Nexstim Oyj
Company announcement, Helsinki, 7 June 2024 at 9 AM (EEST) Insider Information: Nexstim Plc Announces Planned Alzheimer’s Collaboration with Sinaptica Therapeutics, Inc. Nexstim Plc (NXTMH:HEX)...
Finnish Hospital Orders Nexstim NBS System 5
08 mai 2024 02h00 HE
|
Nexstim Oyj
Press release, Helsinki, 8 May 2024 at 9 AM (EEST) Finnish Hospital Orders Nexstim NBS System 5 Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from a...
Health Canada Approves Nexstim NBS 6 System for Treatment of MDD
06 mai 2024 02h00 HE
|
Nexstim Oyj
Press release, Helsinki, 6 May 2024 at 9 AM (EEST) Health Canada Approves Nexstim NBS 6 System for Treatment of MDD Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received approval from...
Nexstim, Inc. and Inomed Inc. Enter into Strategic Alliance Agreement for US Market
03 mai 2024 03h00 HE
|
Nexstim Oyj
Press release, Helsinki, 3 May 2024, 10 AM (EEST) Nexstim, Inc. and Inomed Inc. Enter into Strategic Alliance Agreement for US Market Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces that...
Neurosurgery Customer from Germany Orders Nexstim NBS System 5
26 avr. 2024 08h00 HE
|
Nexstim Oyj
Press release, Helsinki, 26 April 2024 at 3 PM (EEST) Neurosurgery Customer from Germany Orders Nexstim NBS System 5 Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for a new...
Nexstim Plc Business Update Q1 2024
26 avr. 2024 02h00 HE
|
Nexstim Oyj
Press release, Helsinki, 26 April 2024 at 9 AM (EEST) Nexstim Plc Business Update Q1 2024 Nexstim Plc (NXTMH:HEX) (”Nexstim” or ”Company”) announces the key highlights of the Company’s business...